Related Experiment Video
Updated: Jul 23, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Risk Prediction Model for Crohn's Disease Based on Hematological Indicators
A new model using routine blood tests predicts Crohn's disease (CD) risk. This tool aids in early diagnosis and differentiating CD from conditions like intestinal tuberculosis (ITB).
Area of Science:
- Gastroenterology
- Internal Medicine
- Diagnostic Medicine
Background:
- Diagnostic errors are common when distinguishing Crohn's disease (CD) from other conditions like ulcerative colitis (UC) and intestinal tuberculosis (ITB).
- An efficient, rapid, and simple predictive model is crucial for clinical application in CD diagnosis.
- Current diagnostic methods can be invasive and time-consuming, necessitating simpler alternatives.
Purpose of the Study:
- To develop a risk prediction model for CD using five routine laboratory tests.
- To create an early warning system and a visual nomograph for CD risk assessment.
- To provide clinicians with a convenient tool for CD risk determination and differential diagnosis.
Main Methods:
- Retrospective analysis of 310 cases (2020-2022) including CD, UC, non-IBD diseases, and healthy controls.
- Risk prediction models were built using logistic regression based on hematological indices: ESR, Hb, WBC, ALb, and CH.
- Models were evaluated for diagnostic accuracy and visualized using a nomograph.
Main Results:
- Significant differences in ESR, WBC, and WBC/CH ratios were observed between CD and non-CD groups (p < 0.05).
- The WBC/CH ratio showed a strong correlation with CD occurrence (correlation coefficient > 0.4).
- A logistic regression model demonstrated high diagnostic accuracy (AUC=0.86) for CD prediction and (AUC=0.88) for differentiating CD from ITB.
Conclusions:
- A novel CD risk prediction model was successfully established using five conventional hematological indices.
- The model, visualized via a nomograph, offers high diagnostic accuracy for CD and its differentiation from ITB.
- This tool can assist clinicians in better managing CD and reducing patient suffering.
More Related Videos
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF